Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enthonox versus morphine for chest pain in acute myocardial infarction
IRCT20180526039852N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, double-blind trial of nitrous oxide + oxygen and morphine in myocardial infarction (MI) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: chest pain. Started May 2019; status: completed.
02
Drugs
nitrous oxide + oxygenmorphine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20180526039852N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180526039852N1.